دورية أكاديمية

TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease.

التفاصيل البيبلوغرافية
العنوان: TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease.
المؤلفون: Yilmaz, Yusuf, Zeybel, Mujdat, Adali, Gupse, Cosar, Arif Mansur, Sertesen, Elif, Gokcan, Hale, Bahcecioglu, Halil Ibrahim, Sahin, Mustafa, Tulunay, Cansin, Ergun, Ihsan, Turan, Ilker, Idilman, Ilkay Sedakat, Celikel, Cigdem, Kirimlioglu, Hale, Akyol, Gulen, Yilmaz, Funda, Sokmensuer, Cenk, Guveli, Hakan, Akarca, Ulus Salih, Akyuz, Umit
المصدر: Hepatology Forum; 2023 Supplement, Vol. 4, p1-32, 32p
مصطلحات موضوعية: NON-alcoholic fatty liver disease, INSULIN resistance, LIVER transplantation, CLINICAL trials, DECISION making
مستخلص: Nonalcoholic fatty liver disease (NAFLD) is a multisystem disease and is significantly associated with obesity, insulin resistance, type 2 diabetes mellitus, metabolic syndrome, and cardiovascular disease. NAFLD has become the most prevalent chronic liver disease in Western countries, and the proportion of NAFLD-related cirrhosis among patients on liver transplantation waiting lists has increased. In light of the accumulated data about NAFLD, and to provide a common approach with multi-disciplines dealing with the subject, it has become necessary to create new guidance for diagnosing and treating NAFLD. This guidance was prepared following an interdisciplinary study under the leadership of the Turkish Association for the Study of the Liver (TASL), Fatty Liver Special Interest Group. This new TASL Guidance is a practical application guide on NAFLD and was prepared to standardize the clinical approach to diagnosing and treating NAFLD patients. This guidance reflects many advances in the field of NAFLD. The proposals in this guidance are meant to aid decision-making in clinical practice. The guidance is primarily intended for gastroenterology, endocrinology, metabolism diseases, cardiology, internal medicine, pediatric specialists, and family medicine specialists. [ABSTRACT FROM AUTHOR]
Copyright of Hepatology Forum is the property of KARE Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:13075888
DOI:10.14744/hf.2023.2023.0011